NO975710D0 - New dolastatin derivatives, their preparation and use - Google Patents

New dolastatin derivatives, their preparation and use

Info

Publication number: NO975710D0
Authority: NO; Norway
Prior art keywords: preparation; dolastatin derivatives; new dolastatin; new; derivatives
Prior art date: 1995-06-07

Application number

NO975710A

Other languages

Norwegian (no)

Other versions

NO975710L (en

NO318384B1 (en

Inventor

Andreas Haupt

Franz Emling

Cynthia Romerdahl

Original Assignee

Basf Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-07

Filing date

1997-12-05

Publication date

1997-12-05

1997-12-05 Application filed by Basf Ag filed Critical Basf Ag

1997-12-05 Publication of NO975710D0 publication Critical patent/NO975710D0/en

1998-02-02 Publication of NO975710L publication Critical patent/NO975710L/en

2005-03-14 Publication of NO318384B1 publication Critical patent/NO318384B1/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

NO19975710A 1995-06-07 1997-12-05 New dolastatin derivatives, their preparation and use, as well as pharmaceutical compositions containing them. NO318384B1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/472,453 US5831002A (en)	1992-05-20	1995-06-07	Antitumor peptides
PCT/EP1996/002393 WO1996040752A1 (en)	1995-06-07	1996-06-03	Novel dolastatin derivatives, their preparation and use

Publications (3)

Publication Number	Publication Date
NO975710D0 true NO975710D0 (en)	1997-12-05
NO975710L NO975710L (en)	1998-02-02
NO318384B1 NO318384B1 (en)	2005-03-14

Family

ID=23875567

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO19975711A NO317670B1 (en)	1995-06-07	1997-12-05	New dolastatin derivatives, their preparation and use
NO19975710A NO318384B1 (en)	1995-06-07	1997-12-05	New dolastatin derivatives, their preparation and use, as well as pharmaceutical compositions containing them.

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
NO19975711A NO317670B1 (en)	1995-06-07	1997-12-05	New dolastatin derivatives, their preparation and use

Country Status (33)

Country	Link
US (1)	US5831002A (en)
EP (2)	EP0871656B1 (en)
JP (2)	JP3957751B2 (en)
KR (2)	KR100437986B1 (en)
CN (2)	CN1182154C (en)
AR (2)	AR003427A1 (en)
AT (2)	ATE223431T1 (en)
AU (2)	AU725170B2 (en)
BG (2)	BG102125A (en)
BR (2)	BR9609424A (en)
CA (2)	CA2219819C (en)
CO (2)	CO4700526A1 (en)
CZ (2)	CZ293682B6 (en)
DE (2)	DE69623992T2 (en)
DK (2)	DK0832104T3 (en)
ES (2)	ES2188759T3 (en)
HR (2)	HRP960277A2 (en)
HU (2)	HU228071B1 (en)
IL (2)	IL122215A (en)
MX (2)	MX9709146A (en)
MY (2)	MY119042A (en)
NO (2)	NO317670B1 (en)
NZ (2)	NZ310443A (en)
PL (2)	PL185763B1 (en)
PT (2)	PT871656E (en)
RO (2)	RO118953B1 (en)
SI (2)	SI0832104T1 (en)
SK (1)	SK282466B6 (en)
TR (2)	TR199701545T1 (en)
TW (2)	TW508357B (en)
UA (2)	UA46776C2 (en)
WO (2)	WO1996040752A1 (en)
ZA (2)	ZA964710B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5807984A (en) *	1995-11-09	1998-09-15	Basf Aktienegesellschaft	Oligopeptides, the preparation and use thereof
TW474946B (en) *	1995-12-15	2002-02-01	Basf Ag	Novel compounds, the preparation and use thereof
US20010009901A1 (en) *	1996-12-11	2001-07-26	Basf Aktiengesellschaft Germany	Antineoplastic peptides
US5965537A (en) *	1997-03-10	1999-10-12	Basf Aktiengesellschaft	Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
US6103698A (en)	1997-03-13	2000-08-15	Basf Aktiengesellschaft	Dolastatin-15 derivatives in combination with taxanes
US6143721A (en) *	1997-07-18	2000-11-07	Basf Aktiengesellschaft	Dolastatin 15 derivatives
US6015790A (en) *	1997-10-06	2000-01-18	Basf Aktiengesellschaft	Methods and compositions for treating rheumatoid arthritis
US5985837A (en) *	1998-07-08	1999-11-16	Basf Aktiengesellschaft	Dolastatin 15 derivatives
CA2360740A1 (en)	1999-03-02	2000-09-08	Boehringer Ingelheim Pharmaceuticals, Inc.	Compounds useful as reversible inhibitors of cathepsin s
US6420364B1 (en)	1999-09-13	2002-07-16	Boehringer Ingelheim Pharmaceuticals, Inc.	Compound useful as reversible inhibitors of cysteine proteases
EP1229934B1 (en)	1999-10-01	2014-03-05	Immunogen, Inc.	Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
EP1381668A1 (en)	2001-04-27	2004-01-21	The Procter & Gamble Company	Compounds, compositions, and methods for controlling biofilms
AU2002359792A1 (en) *	2001-12-18	2003-06-30	Proteologics, Inc.	Methods and compositions for the inhibition of viral release
EP1531846A4 (en) *	2002-02-27	2006-04-19	Us Gov Health & Human Serv	LIGAND CONJUGATES, ADAPTER AND CYTOTOXIC AGENT, RELATED COMPOSITIONS AND RELATED METHODS OF USE
WO2006013552A2 (en)	2004-08-02	2006-02-09	Ramot At Tel Aviv University Ltd.	Articles of peptide nanostructures and method of forming the same
CA2607940C (en)	2005-05-18	2009-12-15	Aegera Therapeutics Inc.	Bir domain binding compounds
JP2009504751A (en) *	2005-08-19	2009-02-05	アメリカ合衆国	Topical preparation of histone deacetylase inhibitor and method of use thereof
EP1973928A2 (en) *	2005-10-11	2008-10-01	Ramot at Tel-Aviv University Ltd.	Self-assembled fmoc-ff hydrogels
MY159563A (en)	2006-05-16	2017-01-13	Pharmascience Inc	Iap bir domain binding compounds
JP5452223B2 (en) *	2006-07-24	2014-03-26	テトラロジックファーマシューティカルズコーポレーション	IAP inhibitor
US7985879B2 (en) *	2007-04-12	2011-07-26	Scinopharm Taiwan Ltd.	Process for making galantamine
UY32099A (en)	2008-09-11	2010-04-30	Enanta Pharm Inc	HEPATITIS C SERINA PROTEASAS MACROCYCLIC INHIBITORS
US8283372B2 (en)	2009-07-02	2012-10-09	Tetralogic Pharmaceuticals Corp.	2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic
NZ602368A (en)	2010-02-12	2014-10-31	Pharmascience Inc	Iap bir domain binding compounds
EP2658858A4 (en)	2010-12-30	2014-06-25	Enanta Pharm Inc	Phenanthridine macrocyclic hepatitis c serine protease inhibitors
MX2013007677A (en)	2010-12-30	2013-07-30	Abbvie Inc	Macrocyclic hepatitis c serine protease inhibitors.
US10201584B1 (en)	2011-05-17	2019-02-12	Abbvie Inc.	Compositions and methods for treating HCV
US9796754B2 (en)	2011-05-27	2017-10-24	Ambrx, Inc.	Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
WO2015103490A1 (en)	2014-01-03	2015-07-09	Abbvie, Inc.	Solid antiviral dosage forms
WO2023033129A1 (en)	2021-09-03	2023-03-09	東レ株式会社	Pharmaceutical composition for treating and/or preventing cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4816444A (en) *	1987-07-10	1989-03-28	Arizona Board Of Regents, Arizona State University	Cell growth inhibitory substance
US4879278A (en) *	1989-05-16	1989-11-07	Arizona Board Of Regents	Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
EP0598129B1 (en) *	1991-08-09	2000-03-22	Teikoku Hormone Mfg. Co., Ltd.	Novel tetrapeptide derivative
JP3523253B2 (en) *	1992-05-20	2004-04-26	アボットゲーエムベーハーウントカンパニーカーゲー	Dolastatin derivatives
US5530097A (en) *	1994-08-01	1996-06-25	Arizona Board Of Regents Acting On Behalf Of Arizona State University	Human cancer inhibitory peptide amides
US5504191A (en) *	1994-08-01	1996-04-02	Arizona Board Of Regents Acting On Behalf Of Arizona State University	Human cancer inhibitory pentapeptide methyl esters

1995
- 1995-06-07 US US08/472,453 patent/US5831002A/en not_active Expired - Lifetime
1996
- 1996-06-03 TR TR97/01545T patent/TR199701545T1/en unknown
- 1996-06-03 UA UA98010070A patent/UA46776C2/en unknown
- 1996-06-03 WO PCT/EP1996/002393 patent/WO1996040752A1/en not_active Ceased
- 1996-06-03 TR TR97/01544T patent/TR199701544T1/en unknown
- 1996-06-03 CZ CZ19973763A patent/CZ293682B6/en not_active IP Right Cessation
- 1996-06-03 AU AU61242/96A patent/AU725170B2/en not_active Ceased
- 1996-06-03 SK SK1653-97A patent/SK282466B6/en not_active IP Right Cessation
- 1996-06-03 ES ES96918661T patent/ES2188759T3/en not_active Expired - Lifetime
- 1996-06-03 MX MX9709146A patent/MX9709146A/en unknown
- 1996-06-03 NZ NZ310443A patent/NZ310443A/en not_active IP Right Cessation
- 1996-06-03 CN CNB961944676A patent/CN1182154C/en not_active Expired - Fee Related
- 1996-06-03 EP EP96918661A patent/EP0871656B1/en not_active Expired - Lifetime
- 1996-06-03 JP JP50013197A patent/JP3957751B2/en not_active Expired - Fee Related
- 1996-06-03 HU HU9801910A patent/HU228071B1/en not_active IP Right Cessation
- 1996-06-03 KR KR1019970709064A patent/KR100437986B1/en not_active Expired - Fee Related
- 1996-06-03 CA CA002219819A patent/CA2219819C/en not_active Expired - Fee Related
- 1996-06-03 BR BR9609424-9A patent/BR9609424A/en not_active Application Discontinuation
- 1996-06-03 CA CA002219818A patent/CA2219818C/en not_active Expired - Fee Related
- 1996-06-03 PL PL96323726A patent/PL185763B1/en unknown
- 1996-06-03 EP EP96918660A patent/EP0832104B1/en not_active Expired - Lifetime
- 1996-06-03 WO PCT/EP1996/002392 patent/WO1996040751A1/en not_active Ceased
- 1996-06-03 AT AT96918660T patent/ATE223431T1/en active
- 1996-06-03 JP JP50013297A patent/JP4221062B2/en not_active Expired - Fee Related
- 1996-06-03 SI SI9630539T patent/SI0832104T1/en unknown
- 1996-06-03 CN CNB961944684A patent/CN1182153C/en not_active Expired - Fee Related
- 1996-06-03 RO RO97-02264A patent/RO118953B1/en unknown
- 1996-06-03 AT AT96918661T patent/ATE224910T1/en active
- 1996-06-03 DE DE69623992T patent/DE69623992T2/en not_active Expired - Lifetime
- 1996-06-03 DE DE69623472T patent/DE69623472T2/en not_active Expired - Lifetime
- 1996-06-03 RO RO97-02254A patent/RO119783B1/en unknown
- 1996-06-03 KR KR1019970709063A patent/KR100437985B1/en not_active Expired - Fee Related
- 1996-06-03 PT PT96918661T patent/PT871656E/en unknown
- 1996-06-03 NZ NZ310444A patent/NZ310444A/en not_active IP Right Cessation
- 1996-06-03 AU AU61241/96A patent/AU725164B2/en not_active Ceased
- 1996-06-03 DK DK96918660T patent/DK0832104T3/en active
- 1996-06-03 IL IL12221596A patent/IL122215A/en not_active IP Right Cessation
- 1996-06-03 DK DK96918661T patent/DK0871656T3/en active
- 1996-06-03 BR BR9609423A patent/BR9609423A/en not_active Application Discontinuation
- 1996-06-03 ES ES96918660T patent/ES2186783T3/en not_active Expired - Lifetime
- 1996-06-03 MY MYPI96002155A patent/MY119042A/en unknown
- 1996-06-03 IL IL12221696A patent/IL122216A/en not_active IP Right Cessation
- 1996-06-03 SI SI9630550T patent/SI0871656T1/en unknown
- 1996-06-03 CZ CZ19973765A patent/CZ293683B6/en not_active IP Right Cessation
- 1996-06-03 MX MX9709147A patent/MX9709147A/en unknown
- 1996-06-03 PL PL96323723A patent/PL185762B1/en unknown
- 1996-06-03 HU HU9801817A patent/HU228073B1/en not_active IP Right Cessation
- 1996-06-03 UA UA98010069A patent/UA46775C2/en unknown
- 1996-06-03 PT PT96918660T patent/PT832104E/en unknown
- 1996-06-04 MY MYPI96002170A patent/MY124487A/en unknown
- 1996-06-06 ZA ZA9604710A patent/ZA964710B/en unknown
- 1996-06-06 ZA ZA9604711A patent/ZA964711B/en unknown
- 1996-06-06 AR ARP960102981A patent/AR003427A1/en active IP Right Grant
- 1996-06-06 AR ARP960102980A patent/AR003136A1/en active IP Right Grant
- 1996-06-06 HR HR08/472,453A patent/HRP960277A2/en not_active Application Discontinuation
- 1996-06-06 HR HR08/472,453A patent/HRP960257A2/en not_active Application Discontinuation
- 1996-06-07 CO CO96029749A patent/CO4700526A1/en unknown
- 1996-06-07 CO CO96029751A patent/CO4700527A1/en unknown
- 1996-06-07 TW TW085106866A patent/TW508357B/en not_active IP Right Cessation
- 1996-10-02 TW TW085106867A patent/TW424096B/en not_active IP Right Cessation
1997
- 1997-12-05 NO NO19975711A patent/NO317670B1/en not_active IP Right Cessation
- 1997-12-05 NO NO19975710A patent/NO318384B1/en not_active IP Right Cessation
- 1997-12-18 BG BG102125A patent/BG102125A/en unknown
- 1997-12-29 BG BG102152A patent/BG102152A/en unknown

Also Published As

Publication number	Publication date
UA46775C2 (en)	2002-06-17
UA46776C2 (en)	2002-06-17
IL122216A0 (en)	1998-04-05
IL122215A0 (en)	1998-04-05
EP0871656A1 (en)	1998-10-21
IL122215A (en)	2001-08-26
JP4221062B2 (en)	2009-02-12
DE69623992D1 (en)	2002-10-31
CN1182153C (en)	2004-12-29
CA2219818C (en)	2008-05-20
RO118953B1 (en)	2004-01-30
PL323726A1 (en)	1998-04-14
HUP9801910A2 (en)	1999-01-28
TW424096B (en)	2001-03-01
AR003427A1 (en)	1998-08-05
HRP960277A2 (en)	1997-10-31
HUP9801817A3 (en)	1999-06-28
TW508357B (en)	2002-11-01
NO317670B1 (en)	2004-11-29
BR9609424A (en)	2000-03-28
EP0832104A1 (en)	1998-04-01
PT871656E (en)	2002-12-31
PT832104E (en)	2002-12-31
SI0832104T1 (en)	2003-08-31
KR100437986B1 (en)	2004-09-18
BG102125A (en)	1998-09-30
SI0871656T1 (en)	2003-08-31
SK282466B6 (en)	2002-02-05
PL323723A1 (en)	1998-04-14
HUP9801910A3 (en)	1999-06-28
HUP9801817A2 (en)	1998-11-30
DK0832104T3 (en)	2003-01-06
SK165397A3 (en)	1998-10-07
AU6124296A (en)	1996-12-30
AR003136A1 (en)	1998-07-08
NO975711D0 (en)	1997-12-05
CA2219819A1 (en)	1996-12-19
NO975710L (en)	1998-02-02
WO1996040751A1 (en)	1996-12-19
BG102152A (en)	1998-09-30
MY119042A (en)	2005-03-31
KR100437985B1 (en)	2004-09-18
NO975711L (en)	1998-01-30
MX9709146A (en)	1998-03-31
PL185762B1 (en)	2003-07-31
DE69623472T2 (en)	2003-08-21
TR199701545T1 (en)	1998-04-21
JPH11504653A (en)	1999-04-27
ATE224910T1 (en)	2002-10-15
BR9609423A (en)	1999-06-29
CZ376597A3 (en)	1998-06-17
DK0871656T3 (en)	2003-01-27
NZ310444A (en)	1999-11-29
TR199701544T1 (en)	1998-03-21
ES2188759T3 (en)	2003-07-01
CN1182154C (en)	2004-12-29
AU725164B2 (en)	2000-10-05
CA2219819C (en)	2008-05-20
HU228073B1 (en)	2012-09-28
AU6124196A (en)	1996-12-30
ES2186783T3 (en)	2003-05-16
KR19990022583A (en)	1999-03-25
CO4700527A1 (en)	1998-12-29
AU725170B2 (en)	2000-10-05
JP3957751B2 (en)	2007-08-15
JPH11504652A (en)	1999-04-27
CN1187198A (en)	1998-07-08
NO318384B1 (en)	2005-03-14
EP0832104B1 (en)	2002-09-04
US5831002A (en)	1998-11-03
CZ293682B6 (en)	2004-07-14
CZ293683B6 (en)	2004-07-14
MX9709147A (en)	1998-03-31
DE69623472D1 (en)	2002-10-10
DE69623992T2 (en)	2003-05-22
ZA964711B (en)	1997-12-08
MY124487A (en)	2006-06-30
WO1996040752A1 (en)	1996-12-19
EP0871656B1 (en)	2002-09-25
CA2219818A1 (en)	1996-12-19
HU228071B1 (en)	2012-09-28
IL122216A (en)	2002-02-10
CZ376397A3 (en)	1998-06-17
ATE223431T1 (en)	2002-09-15
PL185763B1 (en)	2003-07-31
RO119783B1 (en)	2005-03-30
CN1187199A (en)	1998-07-08
NZ310443A (en)	1999-10-28
HRP960257A2 (en)	1998-02-28
CO4700526A1 (en)	1998-12-29
KR19990022582A (en)	1999-03-25
ZA964710B (en)	1997-12-08

Publication	Publication Date	Title
NO975710L (en)	1998-02-02	New dolastatin derivatives, their preparation and use
NO980720D0 (en)	1998-02-20	Pyridazine-3-one derivatives, their use and intermediates for their preparation
NO990012D0 (en)	1999-01-04	New erythromycins and methods for their preparation
DK0836615T3 (en)	2003-08-11	New thrombin inhibitors, their preparation and use
NO954369D0 (en)	1995-11-01	Oxazolidinedione derivatives, their preparation and use
NO961160L (en)	1996-09-25	Cyclic compounds, their preparation and use
NO991761D0 (en)	1999-04-14	New piperidine cotocarboxylic acid derivatives, their preparation and use
NO20005266D0 (en)	2000-10-19	Novel substituted amides, their preparation and use
NO943682D0 (en)	1994-10-03	Imidazol-4-yl-piperidine derivatives, their preparation and therapeutic use
NO952677D0 (en)	1995-07-06	New dihydropyrrolopyridinone and oxazolopyridinone compounds, their preparation and pharmaceutical preparations
NO961721D0 (en)	1996-04-29	2-oxetanone adhesives, their preparation and use
NO984717D0 (en)	1998-10-09	New hydroxamic acid derivatives, their preparation and use
NO975020D0 (en)	1997-10-31	Azacycloalkane derivatives, their preparation and their use in therapy
NO953673D0 (en)	1995-09-18	[1,2,4ÅTriazolo [4,3-aquinoxaline derivatives, their preparation and use
DK0835254T3 (en)	2000-03-27	Oxazolidinone derivatives, their preparation and their therapeutic use
NO962477D0 (en)	1996-06-12	Benzamide derivatives, their preparation and their therapeutic use
NO954763D0 (en)	1995-11-24	Piperidine derivatives, their preparation and use
NO984624D0 (en)	1998-10-02	New furan-diarylmethylidene derivatives, methods of their preparation and therapeutic uses thereof
NO980471D0 (en)	1998-02-03	Benzenesulfonamide derivatives, their preparation and therapeutic uses thereof
NO973230D0 (en)	1997-07-11	New peptides, their preparation and use
NO971424D0 (en)	1997-03-25	Novel heterocyclic substituted imidazoloquinoxalidones, their preparation and use
NO955242D0 (en)	1995-12-22	Piperidine derivatives, processes for their preparation and their therapeutic use
NO20000066D0 (en)	2000-01-06	6-Pyrrolidin-2-ylpyrindine Derivatives, their Preparation and their Pharmaceutical Use
NO982105D0 (en)	1998-05-08	New intermediates and their use for the preparation of N, N'-bridged bisindolylmaleimides
NO20003128D0 (en)	2000-06-16	Novel β-aminophenyl derivatives and their use

Legal Events

Date	Code	Title	Description
2014-06-02	CHAD	Change of the owner's name or address (par. 44 patent law, par. patentforskriften)	Owner name: ABBVIE DEUTSCHLAND GMBH & CO AG, DE
2016-01-25	MM1K	Lapsed by not paying the annual fees